Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients
Authors:
Open Access
- 1 October 1998
- journal article
- clinical trial
- Published by Springer Nature in Leukemia
- Vol. 12 (10) , 1627-1629
Abstract
Prompt empiric antibiotic therapy is of critical importance for patients with neutropenic fever. However, a major concern with important clinical consequences is the emergence of bacterial resistance to antibiotics. After using ceftazidime with a glycopeptide as initial empiric therapy for neutropenic fever, we were confronted with a 75% reduced susceptibility rate to ceftazidime of inducible Enterobacteriaceae collected in 1994. The initial empiric therapy was therefore replaced in May 1995 by a combination of cefepime with amikacin, with addition of a glycopeptide after 48 h if necessary. After this change, we observed a significant decrease in reduced susceptibility of inducible Enterobacteriaceae, not only to ceftazidime, but also to amikacin, cotrimoxazole and ciprofloxacin. There was also a decrease in reduced susceptibility of non-inducible Enterobacteriaceae, such as Klebsiella spp, to ceftazidime. The reduction of resistance may be related at least in part to the combined use of cefepime together with an aminoglycoside. This study shows that it is possible to reverse bacterial resistance by modifying the antibiotic regimen used.Keywords
This publication has 8 references indexed in Scilit:
- The Relationship Between Antecedent Antibiotic Use and Resistance to Extended-Spectrum Cephalosporins in Group I -Lactamase-Producing OrganismsClinical Infectious Diseases, 1995
- Cefepime: overview of activity in vitro and in vivoJournal of Antimicrobial Chemotherapy, 1993
- Management of Fever in Patients with Cancer and Treatment-Induced NeutropeniaNew England Journal of Medicine, 1993
- -Lactam Resistance in Gram-Negative Bacteria: Global Trends and Clinical ImpactClinical Infectious Diseases, 1992
- Alterations in the Microbial Flora and in the Incidence of Bacteremia at a University Hospital after Adoption of Amikacin as the Sole Formulary AminoglycosideClinical Infectious Diseases, 1992
- Trends in antibiotic utilization and bacterial resistanceDiagnostic Microbiology and Infectious Disease, 1992
- Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during TherapyAnnals of Internal Medicine, 1991
- Evaluation of the LOGIC system for the rapid identification of members of the family Enterobacteriaceae in the clinical microbiology laboratoryJournal of Clinical Microbiology, 1990